Grünenthal Strengthens Global Regulatory Information Management with Veeva RIM

Grünenthal Enhances Global Regulatory Operations with Veeva RIM

In a significant move to strengthen its global regulatory framework, Grünenthal has adopted Veeva Regulatory Information Management (RIM) to optimize the way it handles regulatory information. With the healthcare landscape constantly evolving, the need for agile responses to regulatory changes is essential. Veeva RIM allows Grünenthal to consolidate its regulatory information management onto a single cloud platform, which means that the company can more effectively navigate the requirements set forth by health authorities around the world.

Argha Nag, Vice President and Head of RIM and Digital Transformation at Grünenthal, emphasized the transformative potential of this integration: "By utilizing Veeva RIM, we are simplifying our global regulatory processes, enhancing oversight and visibility of our data, and increasing interdepartmental collaboration. Ultimately, this enables us to deliver safe and effective medications to patients more efficiently."

One of the key advantages of Veeva RIM is its ability to break down data silos that often hinder workflow efficiency. By providing a unified approach, teams can focus on strategic tasks rather than getting bogged down in manual processes. As Grünenthal continues to lead in pain management, addressing unmet medical needs globally becomes even more critical.

The platform enhances coordination among Grünenthal’s global regulatory teams, allowing for better data oversight and flexibility to scale operations as needed. Integrating various regulatory processes into one application not only aids in compliance but also equips teams to respond quickly to regulatory demands. Paul Attridge, Vice President of RIM at Veeva, remarked, "Veeva RIM offers Grünenthal a comprehensive data and workflow platform that enables a deeper understanding of their regulatory processes. This improves their ability to make faster, more informed decisions, facilitating quicker delivery of crucial pain management treatments to patients."

Veeva RIM is a part of the broader Veeva Development Cloud, which provides a robust technological foundation for product development, integrating clinical, quality, regulatory, and safety applications to streamline business processes. This seamless integration fosters operational excellence across all regulatory activities, which is particularly beneficial for companies like Grünenthal that operate in high-stakes healthcare environments.

To find more information about Veeva RIM and its capabilities, interested parties can visit Veeva's website. Additionally, Veeva can be followed on LinkedIn for updates on their organizational achievements and innovations.

About Veeva Systems

Veeva Systems is recognized as a global leader in cloud software for life sciences. With a commitment to innovation and customer success, Veeva serves over 1,000 clients ranging from the world’s largest biopharmaceutical firms to emerging biotechnology companies. As a Public Benefit Corporation, Veeva pledges to balance the interests of all stakeholders—customers, employees, and the industries it serves. For further details on Veeva, please visit veeva.com/eu.

Forward-Looking Statements

This article includes forward-looking statements about Veeva's products and the expected results from utilizing them. These anticipations are based on current expectations and facts may diverge significantly from those presented. Numerous risks could adversely affect the outcomes, including those disclosed in Veeva’s filings with the SEC. For a detailed overview of potential risks, refer to Veeva's Form 10-Q filed for the period ending April 30, 2025.